Abstract
Arterial hypertension of adrenal etiology is mainly attributed to primary hyperaldosteronism. However, subtle expressions of hyperadrenergic or glucocorticoid excess can also generate arterial hypertension. The present report describes two hypertensive patients cataloged as resistant essential hypertensives, in whom adrenal masses were found incidentally, who highlight the need to recognize these tenuous clinical or laboratory presentations. Case 1 was a 50-yr-old female with hyperadrenergic hypertension associated to a left adrenal node, normal cortisol and aldosterone:renin ratio, marginally increased urinary normetanephrine, and a positive 131I MIBG radioisotope scan. Adrenalectomy normalized blood pressure and urinary metanephrines. Pathology showed a hyperplastic adrenal medulla associated to a multinodular cortical hyperplasia. Case 2 was a 62-yr-old female with progressive hypertension, a slight Cushing phenotype, non-suppressible hypercortisolism, normal urinary metanephrines, and bilateral adrenal nodes. Bilateral adrenalectomy and subsequent replacement normalized blood pressure and phenotypic stigmata. Pathology demonstrated bilateral cortical multinodular hyperplasia and medullary hyperplasia. The clinical study in both patients was negative for MEN. The apparently rare association of cortical and medullary lesions presented by both patients is probably overlooked in routine pathology exams, but should be meticulously searched since the crosstalk between the adrenal cortex and medulla may prompt dual abnormalities.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Omura, M., Saito, J., Yamaguchi, K., Kakuta, Y., and Nishikawa, T. (2004). Hypertens. Res. 27, 193–202.
Fardella, C. E. and Mosso, L. (2002). Clin. Lab. 48, 181–190.
Lender, J. W., Eisenhofer, G., Mannelli, M., and Pacak, K. (2005). Lancet 366, 665–675.
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., and Bornstein, S. R. (2004). Endocr. Rev. 25, 309–340.
Bornstein, S. R., Gonzalez-Hernandez, J. A., Ehrhart-Bornstein, M., Adler, G., and Scherbaum, W. A. (1994). J. Clin. Endocrinol. Metab. 78, 225–232.
Schinner, S. and Bornstein, S. R. (2005). Endocr. Pathol. 16, 91–98.
Montalbano, F. P., Baronosfsky, I. D., and Ball, H. (1962). JAMA 182, 264–267.
Carney, J. A., Sizemore, G. W., and Sheps, S. G. (1976). Am. J. Clin. Pathol. 66, 279–290.
Qupty, G., Ishay, A., Peretz, H., Dharan, M., Kaufman, N., and Luboshitzky, R. (1997). Clin. Endocrinol. (Oxf.) 47, 613–617.
Rudy, F. R., Bates, R. D., Cimorelli, A. J., and Hill, G. S. (1980). Hum. Pathol. 11, 650–657.
Yung, B. C. K., Loke, T. K., Tse, T. W., and James, C. S. (2000). Eur. J. Radiol. 36, 28–31.
Visser, J. W. and Axt, R. (1975). J. Clin. Pathol. 28, 208–298.
DeLellis, R. A., Wolfe, H. J., Gagel, R. F., et al. (1976). Am. J. Pathol. 83, 177–196.
Carney, J. A., Gordon, H., Carpenter, P. C., Shenoy, B. L., and Go, V. L. (1985). Medicine (Baltimore) 64, 270–283.
Stratakis, C. A. and Kirschner, L. S. (1998). Horm. Metab. Res. 30, 456–463.
Chrousos, G. P., tera-Wadleigh, S. D., and Karl, M. (1993). Ann. Intern. Med. 119, 1113–1124.
Bray, P. J. and Cotton, R. G. (2003). Hum. Mutat. 21, 557–568.
Hurley, D. M., Accili, D., Stratakis, C. A., et al. (1991). J. Clin. Invest. 87, 680–686.
Malchoff, D. M., Brufsky, A., Reardon, G., et al. (1993). J. Clin. Invest. 91, 1918–1925.
Krall, P., Mosso, L., Carvajal, C., Rojas, A., and Fardella, C. J. (2006). Hypertension, in press.
Moleman, P., Tulen, J. H., Blankestijn, P. J., Man in’t Veld, A. J., and Boomsma, F. (1992). Arch. Gen. Psychiatry 49, 568–572.
Lindberg, S., Fjalling, M., Jacobsson, L., Jansson, S., and Tisell, L. E. (1988). J. Nucl. Med. 29, 1638–1643.
Manger, W. M. and Gifford, R. W. (1996). In: Clinical and experimental pheochromocytoma. Manger, W. M. and Gifford, R. W. (eds.). Blackwell Science: Malden, MA.
Khorram-Manesh, A., Ahhnan, H., Nilsson, O., et al. (2005). J. Intern. Med. 258, 55–66.
Reincke, M. (2000). Endocrinol. Metab. Clin. North Am. 29, 43–56.
Rossi, R., Tauchmanova, L., Luciano, A., et al. (2000). J. Clin. Endocrinol. Metab. 85, 1440–1448.
Bisceglia, M., Nirchio, V., Attino, V., Di, C. A., Mantovani, W., and Pasquinelli, G. (1998). Pathologica 90, 306–312.
Borrero, E., Katz, P., Lipper, S., and Chang, J. B. (1987). Angiology 38, 271–274.
Krubsack, A. J., Arnaout, M. A., Hagen, T.C., et al. (1988). Clin. Nucl. Med. 13, 730–733.
Sato, H., Igarashi, H., Kishimoto, Y., et al. (2002). Int. J. Urol. 9, 398–401.
Yoshioka, M., Saito, H., Kawakami, Y., Mineyama, H., and Sekiya, M. (1993). Endocr. J. 40, 467–471.
Bornstein, S. R., Ehrhart-Bornstein, M., Usadel, H., Kreysch, H. G., and Scherbaum, W. A. (1991). Cell Tissue Res. 265, 1–9.
Davis, K. T., Prentice, N., Gay, V. L., and Murray, S. A. (2002). J. Endocrinol. 173, 13–21.
Murray, S. A., Davis, K., and Gay, V. (2003). Microsc. Res. Tech. 61, 240–246.
Shepherd, S. P. and Holzwarth, M. A. (1996). Endocr. Res. 22, 839–843.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Valdés, G., Roessler, E., Salazar, I. et al. Association of adrenal medullar and cortical nodular hyperplasia. Endocr 30, 389–396 (2006). https://doi.org/10.1007/s12020-006-0019-y
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s12020-006-0019-y